RA Capital Nexus Fund, L.P. is Director & 10% Owner at Vor Biopharma Inc. (VOR). They have made 5 open-market trades across 4 companies since 2021, most recently 2025-10-21.
CIK 0001780117
4 open-market purchases totalling $57.9M since 2021, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ETNB | 8,955,410 | $132.9M |
| VOR | 1,426,253 | $25.7M |
| SLDB | 4,192,216 | $23.3M |
| TYRA | 442,721 | $8.2M |
| Total | $190.1M |
Shares reported on the most recent Form 4, priced at the 2025-10-22 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VOR | SELL | 2025-10-20 | 2025-10-22 | $29.33 | $6.8M | -13.0% | -71.1% | -31.7% |
| SLDB | BUY | 2024-01-11 | 2024-01-12 | $5.53 | $10.0M | -2.3% | -2.7% | +28.6% |
| ETNB | BUY | 2022-10-18 | 2022-10-20 | $7.65 | $17.9M | +7.1% | -4.2% | +23.6% |
| ETNB | BUY | 2022-07-01 | 2022-07-06 | $3.55 | $10.0M | -1.2% | +9.1% | +97.0% |
| TYRA | BUY | 2021-09-17 | 2021-09-17 | $16.00 | $20.0M | -10.8% | -3.9% | -27.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.